VEGFA and hepatocellular carcinoma: Similarly, miR-195 has been shown to impede angiogenesis by targeting proteins such as VEGF, Vav guanine-nucleotide exchange factor 2 (VAV2), and cell division cycle 42 (CDC42), ubiquitously involved in cancer progression, including HCC [19].